APA (7th ed.) Citation

Chen, X., Tan, B., Xing, H., Zhao, X., Ping, Y., Zhang, Z., . . . Zhang, Y. (2024). Allogeneic CAR-T cells with of HLA-A/B and TRAC disruption exhibit promising antitumor capacity against B cell malignancies. Cancer Immunology, Immunotherapy, 73(1), 1. https://doi.org/10.1007/s00262-023-03586-1

Chicago Style (17th ed.) Citation

Chen, Xinfeng, et al. "Allogeneic CAR-T Cells with of HLA-A/B and TRAC Disruption Exhibit Promising Antitumor Capacity Against B Cell Malignancies." Cancer Immunology, Immunotherapy 73, no. 1 (2024): 1. https://doi.org/10.1007/s00262-023-03586-1.

MLA (9th ed.) Citation

Chen, Xinfeng, et al. "Allogeneic CAR-T Cells with of HLA-A/B and TRAC Disruption Exhibit Promising Antitumor Capacity Against B Cell Malignancies." Cancer Immunology, Immunotherapy, vol. 73, no. 1, 2024, p. 1, https://doi.org/10.1007/s00262-023-03586-1.